Trevi Therapeutics, Inc.
Pharmaceutical company · New Haven, Connecticut, United States · Nasdaq: TRVI
Trevi Therapeutics, Inc. is a pharmaceutical company headquartered in New Haven, Connecticut, United States. Its earliest recorded incorporation is in 2011. Its shares trade on Nasdaq under the ticker TRVI. It has reported private securities offerings to the US SEC, most recently $55 million sold in a notice filed in 2022.
Trevi Therapeutics at a glance
What does Trevi Therapeutics do?
Private fundraising reported to the SEC
6 Form D notices; the most recent reported $55 million sold (2022).
Frequently asked questions about Trevi Therapeutics
Where is Trevi Therapeutics headquartered?
Trevi Therapeutics, Inc. is headquartered in New Haven, Connecticut, United States.
What does Trevi Therapeutics do?
Trevi Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Trevi Therapeutics a public company?
Yes. Trevi Therapeutics, Inc. trades on Nasdaq under the ticker TRVI.
When was Trevi Therapeutics founded?
The earliest incorporation on record for Trevi Therapeutics, Inc. is in 2011, according to public company registers.
Similar companies
- Arvinas, Inc.New Haven, Connecticut, United States
- Yarrow Bioscience, Inc.New Haven, Connecticut, United States
- Veradermics, IncNew Haven, Connecticut, United States
- Rallybio CorpNew Haven, Connecticut, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.